EUVIMEDEUVIMED entdecken
Vergleichsstudie

Clinical Utility of β-Hydroxybutyrate vs Anion Gap to Define Resolution of Diabetic Ketoacidosis

Alexandra Cyr, Andrew Faust, Margarita Taburyanskaya, Thomas Brad Raper, Anthony Ortegon

American Journal of Critical Care · 01.07.2026 · 35 (4) · 298-303

DOI: 10.4037/ajcc2026208 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Critical Care, erschienen am 01.07.2026. Verfasst von Alexandra Cyr und 4 weiteren Autor:innen. Beteiligte Einrichtung: Alexandra Cyr is a critical care pharmacy specialist, SSM St Anthony Hospital Department of Pharmacy, Oklahoma City, Oklahoma. At the time of writing…. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, 3-Hydroxybutyric Acid, Acid-Base Equilibrium. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Updated guidelines for managing diabetic ketoacidosis (DKA) preferentially recommend using β-hydroxybutyrate instead of anion gap for determining DKA resolution. Although physiological reasons suggest benefits of β-hydroxybutyrate over anion gap, clinical data supporting this idea are limited.

Objective

To compare time to DKA resolution (time from initial intravenous insulin to first dose of long-acting subcutaneous insulin) between patients managed with β-hydroxybutyrate and patients managed with anion gap.

Methods

This retrospective study evaluated patients with DKA who were managed with the same continuous intravenous insulin protocol at 2 participating sites, one that used β-hydroxybutyrate and the other that used anion gap to assess resolution. The primary outcome was time to first dose of long-acting insulin, with secondary outcomes including incidence of DKA recurrence after transition to subcutaneous insulin.

Results

A total of 178 patients were included, with 89 in the β-hydroxybutyrate–managed arm. Baseline characteristics, including DKA severity, were similar in the 2 groups. Conversion to a long-acting insulin regimen occurred at a median (IQR) of 23.5 (17.9-31.0) hours in the β-hydroxybutyrate group and 13.3 (10.0-18.2) hours in the anion gap group (P < .01) with no difference in rates of DKA recurrence.

Conclusions

Monitoring anion gap rather than β-hydroxybutyrate for DKA resolution led to shorter time on an insulin infusion with no increase in DKA recurrence. Prospective studies evaluating β-hydroxybutyrate thresholds or how to best use β-hydroxybutyrate in practice are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic Ketoacidosis3-Hydroxybutyric AcidAcid-Base EquilibriumHumansRetrospective StudiesFemaleMaleMiddle AgedAdultInsulin, Long-ActingHypoglycemic AgentsInsulinTime Factors

Substanzen

3-Hydroxybutyric AcidInsulin, Long-ActingHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Alexandra Cyr is a critical care pharmacy specialist, SSM St Anthony Hospital Department of Pharmacy, Oklahoma City, Oklahoma. At the time of writing, she was a PGY-2 critical care pharmacy resident at Texas Health Pres…
  • Andrew Faust is a critical care pharmacy specialist, Department of Pharmacy, Texas Health Presbyterian Hospital, Dallas, Texas.
  • Margarita Taburyanskaya is a critical care pharmacy specialist, Texas Health Harris Methodist Hospital, Department of Pharmacy, Fort Worth, Texas.
  • Thomas Brad Raper is an attending intensivist, Sound Pulmonary Critical Care Group, Dallas, Texas.
  • Anthony Ortegon is an attending intensivist, Sound Pulmonary Critical Care Group, Dallas, Texas.

Zitieren

APA

Cyr, A., Faust, A., Taburyanskaya, M., Raper, T. B., & Ortegon, A. (2026). Clinical Utility of β-Hydroxybutyrate vs Anion Gap to Define Resolution of Diabetic Ketoacidosis. American Journal of Critical Care, 35(4), 298-303. https://doi.org/10.4037/ajcc2026208

Vancouver

Cyr A, Faust A, Taburyanskaya M, Raper TB, Ortegon A. Clinical Utility of β-Hydroxybutyrate vs Anion Gap to Define Resolution of Diabetic Ketoacidosis. American Journal of Critical Care. 2026;35(4):298-303. doi:10.4037/ajcc2026208

BibTeX
@article{Cyr2026,
  author = {Cyr, Alexandra and Faust, Andrew and Taburyanskaya, Margarita and Raper, Thomas Brad and Ortegon, Anthony},
  title = {Clinical Utility of β-Hydroxybutyrate vs Anion Gap to Define Resolution of Diabetic Ketoacidosis},
  journal = {American Journal of Critical Care},
  year = {2026},
  volume = {35},
  number = {4},
  pages = {298--303},
  doi = {10.4037/ajcc2026208}
}
Kostenlos starten →